Clinical trial
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
NCT00401388 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00401388 |
|---|---|
| Title | A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas |
| Official title | Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas |
| Lead sponsor | AEterna Zentaris, Industry |
| Collaborators | Sarcoma Alliance for Research through Collaboration |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chondrosarcomas, Alveolar Soft Part Sarcomas, Extra Skeletal Myxoid Chondrosarcomas |
| Intervention type | Drug, Other |
| Interventions | Perifosine, Loperamide, Allopurinol, Antiemetics |
| Enrollment | 72 |
| Start date | Nov 1, 2006 |
| Primary completion | Jan 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Nov 20, 2006 |
| Last update posted | Mar 7, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: